AzTrials
AzTrials

Autism Spectrum DisorderNCT07056387

The Effects of a Nurse-led Community-based Sailing Programme on Resilience of School-aged Children With Autism: An RCT

A study testing A nurse-led community-based sailing programme and Crafting activities in people with Autism Spectrum Disorder and Resilience, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomised controlled trial is to evaluate the effect of a nurse-led community-based sailing programme on resilience of school-aged children with autism in inclusive education. Read more about this study

Who is it for?
Ages 7 to 12 years
Conditions the study is for
Autism Spectrum Disorder, Resilience
What is being tested?
A nurse-led community-based sailing programme and Crafting activities
Could I receive a placebo?
No, everyone receives an active treatment
How many people
184 participants
Where
1 siteHong Kong
Study dates
18 Jul 2025to 8 Oct 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Be between the ages of 7 and 12,
  • Have a confirmed diagnosis of ASD,
  • Be enrolled in an inclusive education school,
  • Possess the ability to complete the questionnaire in Chinese,
  • Be able to communicate in Chinese.

Who cannot join

  • With sailing experience,
  • With a history of severe motion sickness symptoms.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Sailability Hong Kong

    Hong Kong

Other trials in Hong Kong

About this study

Official title: The Effects of a Nurse-led Community-based Sailing Programme on Resilience of School-aged Children With Autism: A Randomised Controlled Trial

The goal of this randomised controlled trial is to evaluate the effect of a nurse-led community-based sailing programme on resilience of school-aged children with autism in inclusive education.

Does intervention improve the resilience of participants? Does intervention improve the quality of life, self-esteem, depressive symptoms, and social functioning outcomes of participants?

Read more

Researchers will compare the effect of intervention (community-based sailing programme) to the attention control group (Crafting activities) at baseline, post-intervention, and at 3-month and 9-month follow-ups.

Participants will:

Participants in the intervention group will participate in a nurse-led community-based sailing programme over six days, with each day consisting of 4 sessions, each lasting an hour, for a total of 24 hours.

Participants in the attention control group will engage in crafting activities with minimal difficulty, focusing on maintaining attention without any emotional or reflective discussions.

Read the detailed description

Autism spectrum disorder (ASD) is a neurodevelopmental condition that typically emerges in early childhood, characterized by persistent deficits in social communication and interaction, with the presence of restricted, repetitive patterns of behaviour, interests, or activities. This study seeks to address the outcome gap in the literature, the resilience of children with ASD, and contribute to their holistic health through integrating nature and the community.

The study hypothesizes that, compared to the attention control group, school-aged children with ASD in inclusive education who participate in the intervention group will exhibit: (1) increased levels of resilience, (2) improved quality of life (QoL), (3) reduced depressive symptoms, (4) enhanced self-esteem, and (5) improved social functioning, both immediately post-intervention and at 3-month and 9-month follow-ups.

Being tested
A nurse-led community-based sailing programme, Crafting activities
Keywords
Sailing, Nature-based interventions, School-aged children
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A nurse-led community-based sailing programmeOther

    A nurse-led community-based sailing programme is validated by an expert panel including professionals from various fields, such as a registered nurse, academia, and qualified sailing instructors, delivered in a group of 6 participants, incorporating experiential learning, with the aid of materials including dinghies with Universal design, safety boats, buoys, buoyancy aids, supplementing with a waterproof sailing booklet. The intervention is developed and facilitated by a registered nurse (principal investigator).

  • Crafting activitiesOther

    Participants in the attention control group will participate in crafting activities. Activities match the time and attention dedicated by the intervention group. Activities are designed to have no impact on resilience.

Study groups in NCT07056387
Study groupRoleWhat they receive
Intervention groupExperimentalEligible participants will participate in the nurse-led CBS programme, utilising dinghies with a universal design known for their exceptional stability to prioritize safety. The concrete experience will be introduced through sailing activities. The instructor-to-participant ratio will be 1:6 with a safety boat present.
Receives: Other: A nurse-led community-based sailing programme
Attention controlled GroupActive comparatorThe attention control group participates in crafting activities (e.g., making handicrafts or painting) to engage participants in an active process, allowing for a comparison of the intervention's effects (sailing programme) against an alternative active activity.
Receives: Other: Crafting activities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resilience

    Resilience will be measured using the 14-item Resilience Scale (RS-14), which assesses personal competence, self-acceptance, and life acceptance. Each item is rated on a 7-point Likert scale (1 = "strongly disagree" to 7 = "strongly agree"), with total scores ranging from 14 to 98. Higher scores indicate greater resilience. The validated Chinese version of the RS-14, with a Cronbach's alpha of 0.86, has demonstrated good internal consistency for assessing resilience in young adolescents in Hong Kong.

    Measured: Pre-intervention, Post-intervention (within 1 week immediately after intervention), and at 3-month and 9-month follow-ups.

Secondary outcomes (4)
  1. Depressive symptoms

    Depressive symptoms will be assessed using the Chinese version of the Center for Epidemiologic Studies Depression Scale for Children (CES-DC). The scale includes 20 items across emotional, cognitive, and behavioral domains of depression. Participants rate the frequency of symptoms over the past week on a 4-point Likert scale (0 = not at all, 1 = a little, 2 = some, 3 = a lot). Total scores range from 0 to 60, with higher scores indicating more severe depressive symptoms. A score of 16 or higher suggests the presence of depressive symptoms. The Chinese version of the CES-DC, validated for use in children in Hong Kong, demonstrates strong internal consistency (Cronbach's alpha > 0.8).

    Measured: Pre-intervention, Post-intervention (within 1 week immediately after intervention), and at 3-month and 9-month follow-ups.

  2. Self-esteem

    Self-esteem will be measured using Rosenberg's Self-Esteem Scale (RSES), a validated tool for assessing global self-worth. The scale comprises 10 items, rated on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree). Total scores range from 10 to 40, with higher scores reflecting higher levels of self-esteem. The Chinese version of the RSES has been validated in Hong Kong, showing good internal consistency (Cronbach's alpha = 0.78).

    Measured: Pre-intervention, Post-intervention (within 1 week immediately after intervention), and at 3-month and 9-month follow-ups.

  3. Quality of life (QoL)

    QoL will be assessed using the Pediatric Quality-of-Life Inventory 4.0 Generic Core Scale (PedsQL™). This 23-item questionnaire evaluates physical functioning (8 items), emotional functioning (5 items), social functioning (5 items), and school functioning (5 items). Participants rate the extent of problems experienced in the past month on a 5-point Likert scale (0 = never to 4 = almost always). Scores are reverse-coded and linearly transformed to a 0-100 scale, with higher scores indicating better QoL. The Chinese version of the PedsQL™, validated in Hong Kong, demonstrates excellent internal consistency (Cronbach's alpha = 0.90).

    Measured: Pre-intervention, Post-intervention (within 1 week immediately after intervention), and at 3-month and 9-month follow-ups.

  4. Social functioning outcomes

    Social functioning will be evaluated using the 2nd edition of the Social Responsiveness Scale (SRS-2), a 65-item questionnaire assessing ASD-related symptoms. Participants' parents rate each item on a 4-point Likert scale (0 = never true to 3 = almost always true). The SRS-2 includes five subscales: social awareness, social cognition, social communication, social motivation, and autistic mannerisms, as well as a total score. Higher scores indicate greater impairment in social functioning. The Chinese version of the SRS-2 has been validated in China, showing strong internal consistency (Cronbach's alpha = 0.90).

    Measured: Pre-intervention, Post-intervention (within 1 week immediately after intervention), and at 3-month and 9-month follow-ups.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2025
  2. Study start18 Jul 2025
  3. Primary completion17 Jan 2026
  4. Study completion8 Oct 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
The intervention is guided by the Synergy Model of Resilience, integrating Kolb's theory of experiential learning.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
184 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07056387
Sponsor's protocol ID
CREC 2025.237-T
Status last verified
Oct 2026
First submitted
29 Jun 2025
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The research team does not have plans to proactively or automatically make the individual participant data (IPD) from this study available to other researchers. However, the IPD may be shared upon request, provided that the requesting party has a valid scientific or medical rationale and obtains the necessary approval from the research team. Any requests for access to the study's IPD will be reviewed on a case-by-case basis by the research team. Factors that will be considered in evaluating such requests include: * Scientific merit and validity of the proposed use of the data * Qualifications and track record of the requesting researcher or research team * Alignment with the original study objectives and participants' consent

Questions about this trial

What is this clinical trial studying?

A study testing A nurse-led community-based sailing programme and Crafting activities in people with Autism Spectrum Disorder and Resilience, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resilience (time frame: Pre-intervention, Post-intervention (within 1 week immediately after intervention), and at 3-month and 9-month follow-ups.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in